Brian Christie - | Life Sciences & Biotech Community | BioTech Funding Portal - BioTech Funding Portal

Ask a Question + Follow

Brian Christie

@BrianChristie

Community Member

|

Board Member

|

Executive

|

Founder

|

Company Owner

|

Service Provider

|

Scientist

|

Featured

|

Co-Founder

|

BioTech Social Inc.

Entrepreneur and inventor operating at the intersection of technology, finance, and regulation.

General Life Sciences

Fabry Disease

Cell & Gene Therapy

Obesity

Featured

Disclaimer: Content on this page is user-provided. BioTech Funding Portal does not verify credentials or statements and does not endorse or guarantee the accuracy of user content. Views expressed are solely those of the individual.

Activity
Profile
Q&A with Brian

Biography

Brian Christie is Chair and Co-founder of BioTech Social Inc., the parent company of BioTech Funding Portal, an SEC-registered, FINRA-member funding portal focused on capital formation for early-stage life science companies. He focuses on expanding access to regulated investment crowdfunding for biotech and life science innovators by building compliant platforms that connect issuers with investors, mentors, and broader innovation networks. He brings deep experience in regulated crowdfunding through his leadership with the Crowdfunding Professional Association (CfPA), where he serves as Vice-Chair, Co-Chair of the Tax Innovation Subcommittee, and Chair of the SEC Liaison & Affairs Subcommittee, following earlier service as President (2024) and board director (2018-present). He is also founding advisor of Crowdfund Holdings Innovators (CHI) and CEO of Brainsy, Inc. He believes regulated investment crowdfunding can help address critical gaps in life science financing, especially where traditional capital is limited.

Related News

03/01/2026: BLPN Letter (Submitted by Caley Anderson, Founding Partner, COO, BLPN-Building Legendary Professional Networks and Brian Christie, Founding Member, BLPN-Building Legendary Professional Networks): Rulemaking Petition to modernize SEC Regulation Crowdfunding (“Reg CF”)

10/24/2025: Crowdfund Insider: Watch: SEC Commissioner Hester Peirce Discusses Mirror Tokens

08/11/2025: Crowdfund Insider: Crowdfunding Professional Association (CfPA) Slams Republic’s “Mirror Token” Offerings

06/11/2025: KOTA News: DC Group says its “Big Beautiful Bill” proposal would bring a lot of money to South Dakota small businesses (Video)

05/29/2005: Crowdfund Insider: Coalition for Crowdfunding American Jobs and Prosperity Hammers Big Beautiful Bill as Missing the Mark

03/14/2025: Benzinga: EXCLUSIVE: TRUMP Act Proposes Tax Credit For Crowdfunding Support For Small Businesses - What It Means, Why It's Important (Login required)

01/28/2025: Crowdfund Insider: CfPA Advocates for Reg CF Tax Exemption: Targeting Resources to Unleash Market Prosperity (TRUMP) Jobs Act

11/06/2024: Superpowers For Good: CfPA Summit Provides a Vision for the Future

04/20/2024: Crowdfund Insider: CfPA Announces Policy Platform for Securities Crowdfunding Industry

Education

Georgetown University

Master of Business Administration (M.B.A.)

Miami University

Bachelor's Degree

Check back later for some activity here. Thank you!

Check back later for some content here. Thank you!

Disclosures

© 2026 BioTech Social Inc. (“BSI”). This website and related services are provided by BSI and BioTech Funding Portal LLC (“BFP”), a wholly owned subsidiary of BSI (collectively, “BioTech Social”). Certain regulated crowdfunding services and offerings available through this website are operated by BFP, while other content, features, and services may be provided, maintained, or supervised by BSI.

BFP is a FINRA member funding portal (FPRD #334156) registered with the U.S. Securities and Exchange Commission (“SEC”). Through BFP, eligible issuers may conduct offerings pursuant to Regulation Crowdfunding, and persons 18 years of age or older may review and invest in such offerings.

Offerings conducted by life science companies are subject to industry-specific risks, including but not limited to regulatory approval and clearance risk, clinical and development risk, intellectual property risk, commercialization risk, manufacturing and supply chain risk, and capital formation risk. Please review the applicable offering materials for additional information.

Investment offerings are speculative, illiquid, and involve a high degree of risk, including the possible loss of an investor's entire investment. Past performance of any security, company, project, management team, or technology is not indicative of future results.

Neither BFP nor BSI provides investment advice, recommendations, or suitability determinations. Neither BFP nor BSI provides tax, accounting, legal, or regulatory advice. Investors must make their own investment decisions and conduct their own due diligence prior to investing. The content contained herein does not constitute a solicitation of an offer to buy or sell any security.

By using this website, you agree to be bound by our Terms of Use, Privacy Policy, and Electronic Consent. Please review these carefully before using the website.

Hide Disclosure